Literature DB >> 22033225

Dynamic changes in oxygenation of intracranial tumor and contralateral brain during tumor growth and carbogen breathing: a multisite EPR oximetry with implantable resonators.

Huagang Hou1, Ruhong Dong, Hongbin Li, Benjamin Williams, Jean P Lariviere, S K Hekmatyar, Risto A Kauppinen, Nadeem Khan, Harold Swartz.   

Abstract

INTRODUCTION: Several techniques currently exist for measuring tissue oxygen; however technical difficulties have limited their usefulness and general application. We report a recently developed electron paramagnetic resonance (EPR) oximetry approach with multiple probe implantable resonators (IRs) that allow repeated measurements of oxygen in tissue at depths of greater than 10mm.
METHODS: The EPR signal to noise (S/N) ratio of two probe IRs was compared with that of LiPc deposits. The feasibility of intracranial tissue pO(2) measurements by EPR oximetry using IRs was tested in normal rats and rats bearing intracerebral F98 tumors. The dynamic changes in the tissue pO(2) were assessed during repeated hyperoxia with carbogen breathing.
RESULTS: A 6-10 times increase in the S/N ratio was observed with IRs as compared to LiPc deposits. The mean brain pO(2) of normal rats was stable and increased significantly during carbogen inhalation in experiments repeated for 3months. The pO(2) of F98 glioma declined gradually, while the pO(2) of contralateral brain essentially remained the same. Although a significant increase in the glioma pO(2) was observed during carbogen inhalation, this effect declined in experiments repeated over days.
CONCLUSION: EPR oximetry with IRs provides a significant increase in S/N ratio. The ability to repeatedly assess orthotopic glioma pO(2) is likely to play a vital role in understanding the dynamics of tissue pO(2) during tumor growth and therapies designed to modulate tumor hypoxia. This information could then be used to optimize chemoradiation by scheduling treatments at times of increased glioma oxygenation. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22033225      PMCID: PMC3730127          DOI: 10.1016/j.jmr.2011.09.043

Source DB:  PubMed          Journal:  J Magn Reson        ISSN: 1090-7807            Impact factor:   2.229


  37 in total

1.  Development and evaluation of biocompatible films of polytetrafluoroethylene polymers holding lithium phthalocyanine crystals for their use in EPR oximetry.

Authors:  M Dinguizli; S Jeumont; N Beghein; J He; T Walczak; P N Lesniewski; H Hou; O Y Grinberg; Artur Sucheta; H M Swartz; B Gallez
Journal:  Biosens Bioelectron       Date:  2005-04-15       Impact factor: 10.618

2.  Simultaneous measurement of rat brain cortex PtO2 using EPR oximetry and a fluorescence fiber-optic sensor during normoxia and hyperoxia.

Authors:  Julia A O'Hara; Huagang Hou; Eugene Demidenko; Roger J Springett; Nadeem Khan; Harold M Swartz
Journal:  Physiol Meas       Date:  2005-02-25       Impact factor: 2.833

3.  Simultaneous multi-site EPR spectroscopy in vivo.

Authors:  A I Smirnov; S W Norby; R B Clarkson; T Walczak; H M Swartz
Journal:  Magn Reson Med       Date:  1993-08       Impact factor: 4.668

Review 4.  Clinical results of hypoxic cell radiosensitisation from hyperbaric oxygen to accelerated radiotherapy, carbogen and nicotinamide.

Authors:  M Saunders; S Dische
Journal:  Br J Cancer Suppl       Date:  1996-07

5.  Implantable resonators--a technique for repeated measurement of oxygen at multiple deep sites with in vivo EPR.

Authors:  Hongbin Li; Huagang Hou; Artur Sucheta; Benjamin B Williams; Jean P Lariviere; Md Nadeem Khan; Piotr N Lesniewski; Bernard Gallez; Harold M Swartz
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

6.  A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85.

Authors:  J Overgaard; H S Hansen; M Overgaard; L Bastholt; A Berthelsen; L Specht; B Lindeløv; K Jørgensen
Journal:  Radiother Oncol       Date:  1998-02       Impact factor: 6.280

7.  Change of oxygen pressure in glioblastoma tissue under various conditions.

Authors:  Takaaki Beppu; Katsura Kamada; Yuki Yoshida; Hiroshi Arai; Kuniaki Ogasawara; Akira Ogawa
Journal:  J Neurooncol       Date:  2002-05       Impact factor: 4.130

Review 8.  Hypoxia and aggressive tumor phenotype: implications for therapy and prognosis.

Authors:  Peter Vaupel
Journal:  Oncologist       Date:  2008

9.  Repeated tumor pO(2) measurements by multi-site EPR oximetry as a prognostic marker for enhanced therapeutic efficacy of fractionated radiotherapy.

Authors:  Huagang Hou; Jean P Lariviere; Eugene Demidenko; David Gladstone; Harold Swartz; Nadeem Khan
Journal:  Radiother Oncol       Date:  2008-11-14       Impact factor: 6.280

10.  Relationship between radiobiological hypoxia in tumors and electrode measurements of tumor oxygenation.

Authors:  M R Horsman; A A Khalil; D W Siemann; C Grau; S A Hill; E M Lynch; D J Chaplin; J Overgaard
Journal:  Int J Radiat Oncol Biol Phys       Date:  1994-06-15       Impact factor: 7.038

View more
  20 in total

Review 1.  A review of flux considerations for in vivo neurochemical measurements.

Authors:  David W Paul; Julie A Stenken
Journal:  Analyst       Date:  2015-06-07       Impact factor: 4.616

Review 2.  Using Stable Free Radicals to Obtain Unique and Clinically Useful Data In Vivo in Human Subjects.

Authors:  Harold M Swartz
Journal:  Radiat Prot Dosimetry       Date:  2016-11-24       Impact factor: 0.972

3.  Monitoring oxygen levels in orthotopic human glioma xenograft following carbogen inhalation and chemotherapy by implantable resonator-based oximetry.

Authors:  Huagang Hou; Venkata Krishnamurthy Nemani; Gaixin Du; Ryan Montano; Rui Song; Barjor Gimi; Harold M Swartz; Alan Eastman; Nadeem Khan
Journal:  Int J Cancer       Date:  2014-08-22       Impact factor: 7.396

4.  Spatial oxygenation profiles in tumors during normo- and hyperbaric hyperoxia.

Authors:  Oliver Thews; Peter Vaupel
Journal:  Strahlenther Onkol       Date:  2015-07-02       Impact factor: 3.621

Review 5.  Clinical EPR: unique opportunities and some challenges.

Authors:  Harold M Swartz; Benjamin B Williams; Bassem I Zaki; Alan C Hartford; Lesley A Jarvis; Eunice Y Chen; Richard J Comi; Marc S Ernstoff; Huagang Hou; Nadeem Khan; Steven G Swarts; Ann B Flood; Periannan Kuppusamy
Journal:  Acad Radiol       Date:  2014-02       Impact factor: 3.173

6.  Dynamic EPR Oximetry of Changes in Intracerebral Oxygen Tension During Induced Thromboembolism.

Authors:  Huagang Hou; Nadeem Khan; Sangeeta Gohain; Clifford J Eskey; Karen L Moodie; Kirk J Maurer; Harold M Swartz; Periannan Kuppusamy
Journal:  Cell Biochem Biophys       Date:  2017-04-22       Impact factor: 2.194

7.  Direct and Repeated Clinical Measurements of pO2 for Enhancing Cancer Therapy and Other Applications.

Authors:  Harold M Swartz; Benjamin B Williams; Huagang Hou; Nadeem Khan; Lesley A Jarvis; Eunice Y Chen; Philip E Schaner; Arif Ali; Bernard Gallez; Periannan Kuppusamy; Ann B Flood
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

8.  Carbogen-induced increases in tumor oxygenation depend on the vascular status of the tumor: A multiparametric MRI study in two rat glioblastoma models.

Authors:  Ararat Chakhoyan; Aurélien Corroyer-Dulmont; Marine M Leblond; Aurélie Gérault; Jérôme Toutain; Laurent Chazaviel; Didier Divoux; Edwige Petit; Eric T MacKenzie; François Kauffmann; Nicolas Delcroix; Myriam Bernaudin; Omar Touzani; Samuel Valable
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

9.  Oxygen consumption in T-47D cells immobilized in alginate.

Authors:  B E Larsen; J A Sandvik; J Karlsen; E O Pettersen; J E Melvik
Journal:  Cell Prolif       Date:  2013-08       Impact factor: 6.831

Review 10.  Advances in probes and methods for clinical EPR oximetry.

Authors:  Harold M Swartz; Huagang Hou; Nadeem Khan; Lesley A Jarvis; Eunice Y Chen; Benjamin B Williams; Periannan Kuppusamy
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.